233 related articles for article (PubMed ID: 12215240)
21. Cost-effectiveness analysis of cataract surgery: a global and regional analysis.
Baltussen R; Sylla M; Mariotti SP
Bull World Health Organ; 2004 May; 82(5):338-45. PubMed ID: 15298224
[TBL] [Abstract][Full Text] [Related]
22. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.
Griffiths UK; Wolfson LJ; Quddus A; Younus M; Hafiz RA
Bull World Health Organ; 2004 Sep; 82(9):643-51. PubMed ID: 15628201
[TBL] [Abstract][Full Text] [Related]
23. The global economic burden of alcohol: a review and some suggestions.
Baumberg B
Drug Alcohol Rev; 2006 Nov; 25(6):537-51. PubMed ID: 17132572
[TBL] [Abstract][Full Text] [Related]
24. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
26. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
[TBL] [Abstract][Full Text] [Related]
27. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
Chisholm D; Doran C; Shibuya K; Rehm J
Drug Alcohol Rev; 2006 Nov; 25(6):553-65. PubMed ID: 17132573
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
29. Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau.
Budke CM; Jiamin Q; Qian W; Torgerson PR
Am J Trop Med Hyg; 2005 Jul; 73(1):2-10. PubMed ID: 16014823
[TBL] [Abstract][Full Text] [Related]
30. Human health benefits from livestock vaccination for brucellosis: case study.
Roth F; Zinsstag J; Orkhon D; Chimed-Ochir G; Hutton G; Cosivi O; Carrin G; Otte J
Bull World Health Organ; 2003; 81(12):867-76. PubMed ID: 14997239
[TBL] [Abstract][Full Text] [Related]
31. Estimating the costs and health benefits of water and sanitation improvements at global level.
Haller L; Hutton G; Bartram J
J Water Health; 2007 Dec; 5(4):467-80. PubMed ID: 17878561
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
33. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
[TBL] [Abstract][Full Text] [Related]
34. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
Dowdy DW; Sweat MD; Holtgrave DR
AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
[TBL] [Abstract][Full Text] [Related]
35. The impact of advertising on nicotine replacement therapy demand.
Tauras JA; Chaloupka FJ; Emery S
Soc Sci Med; 2005 May; 60(10):2351-8. PubMed ID: 15748682
[TBL] [Abstract][Full Text] [Related]
36. Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
Shorr AF; Susla GM; Kollef MH
Crit Care Med; 2004 Jan; 32(1):137-43. PubMed ID: 14707572
[TBL] [Abstract][Full Text] [Related]
37. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of interventions for depressed Latinos.
Schoenbaum M; Miranda J; Sherbourne C; Duan N; Wells K
J Ment Health Policy Econ; 2004 Jun; 7(2):69-76. PubMed ID: 15208467
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
[TBL] [Abstract][Full Text] [Related]
40. Increasing tobacco taxes: a cheap tool to increase public health.
van Baal PH; Brouwer WB; Hoogenveen RT; Feenstra TL
Health Policy; 2007 Jul; 82(2):142-52. PubMed ID: 17050031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
